Tag: Human Papillomavirus (HPV)
Sample-to-Answer, Point-of-Care HPV DNA Test Feasible
Test requires six user steps and gives answer in 45 minutes
Vaginal HPV Detected in About 40 Percent of Pregnant Women
Perinatal transmission occurred infrequently; no infections detected at birth persisted at age 6 months
More Parents Citing Safety as Reason for HPV Vaccine Hesitancy
2010 to 2018 saw 15.6 percent annual increase in proportion of parents citing 'safety or side effects' as reason for hesitancy
HPV Self-Collection Kits Increase Uptake of Cervical Cancer Screening
Mailed HPV self-collection kits with appointment-scheduling assistance leads to greater uptake of screening in underscreened women
Young Cancer Survivors Have Increased Risk for HPV-Linked Subsequent Cancer
Significantly increased risk seen for any HPV-associated subsequent malignant neoplasms and oropharyngeal neoplasms
AACR: Awareness That HPV Causes Cancer Is Ebbing Among Americans
Furthermore, U.S. vaccination rates for preteens and teens are well below recommended goals
Mailed Human Papillomavirus Self-Sampling Kits Are Cost-Effective
Findings show it is an economically efficient outreach strategy for increasing cervical cancer screening rates
HPV Vaccine Refusal Explored Among Cancer Survivors
Most of the cancer survivors who refused participation in a trial of the vaccine did so for vaccine-related concerns
HPV Vaccination Rates Increased After ACIP Update for Adults Aged 27 to 45
Immediate increase seen in vaccine administration rate in women; increased slope seen over time postupdate
Countering Antivax Misinformation Ups Parents’ Perceptions of HPV Vaccines
These social media messages build positive attitudes, which are tied to intention to vaccinate
